Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
We have performed mRNA in situ hybridization studies and northern blot analysis in the mouse and human, respectively, to determine the normal gene expression patterns of FMR-1. Expression in the adult mouse was localized to several regions of the brain and the tubules of the testes, which are two of the major organs affected in fragile X syndrome. Universal and very strong expression was observed in early mouse embryos, with differentially decreasing expression during subsequent stages of embryonic development. The early embryonic onset and tissue specificity of FMR-1 gene expression is consistent with involvement in the fragile X phenotype, and also suggests additional organ systems in which clinical manifestations of reduced FMR-1 gene expression may occur.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMRP is an RNA binding protein (Siomi et al., 1993) that is mainly expressed in the central nervous system (CNS) and gonads, and to lesser extent in other tissues (Hinds et al., 1993).”
From Astrocytes in fragile X syndrome (2024) · cites this paper as Hinds et al., 1993
In the citing paper
“Interestingly, the time point of the aberrant functional and structural connectivity coincides with the expression profile of the knockout genes, suggesting that the timing in which ASD risk-genes are functionally active is critical for the development of aberrant connectivity patterns and possibly behavioral symptoms later in life.”
From Dysfunctional Autism Risk Genes Cause Circuit-Specific Connectivity Deficits With Distinct Developmental Trajectories (2018) · cites this paper as Hinds et al. 1993
In the citing paper
“FMR1 plays a pivotal role in early embryotic neurodevelopment (Hinds et al. 1993) whereas the physiological expression of CNTNAP2 begins at around E14 but peaks during adulthood (P56) (Penagarikano et al. 2011).”
From Dysfunctional Autism Risk Genes Cause Circuit-Specific Connectivity Deficits With Distinct Developmental Trajectories (2018) · cites this paper as Hinds et al. 1993
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Self-citationFu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Self-citationInstability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Absence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Self-citationFragile X Genotype Characterized by an Unstable Region of DNA
Yu, S., Pritchard, M., Kremer, E., Lynch, M., Nancarrow, J., Baker, E., Holman, K., Mulley, J. C., Warren, S. T., Schlessinger, D., et al. (1991) · Science · doi:10.1126/science.252.5009.1179 · Cited by 794
Self-citationLubs, H. A. (1969) · PubMed · Cited by 662
A point mutation in the FMR-1 gene associated with fragile X mental retardation
De Boulle, K., Verkerk, A. J. M. H., Reyniers, E., Vits, L., Hendrickx, J., Van Roy, B., Van Den Bos, F., de Graaff, E., Oostra, B. A., & Willems, P. J. (1993) · Nature Genetics · doi:10.1038/ng0193-31 · Cited by 624
Gene‐induced embryological modifications of primordial germ cells in the mouse
Mintz, B., & Russell, E. S. (1957) · Journal of Experimental Zoology · doi:10.1002/jez.1401340202 · Cited by 541
Cited by
Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,035
Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function
Darnell, J. C., Jensen, K. B., Jin, P., Brown, V., Warren, S. T., & Darnell, R. B. (2001) · Cell · doi:10.1016/s0092-8674(01)00566-9 · Cited by 952
Self-citationSerotonin receptor 1A knockout: An animal model of anxiety-related disorder
Ramboz, S., Oosting, R., Amara, D. A., Kung, H. F., Blier, P., Mendelsohn, M., Mann, J. J., Brunner, D., & Hen, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14476 · Cited by 814
Devys, D., Lutz, Y., Rouyer, N., Bellocq, J.-P., & Mandel, J.-L. (1993) · Nature Genetics · doi:10.1038/ng0893-335 · Cited by 780
FMR1 Protein: Conserved RNP Family Domains and Selective RNA Binding
Ashley, C. T., Wilkinson, K. D., Reines, D., & Warren, S. T. (1993) · Science · doi:10.1126/science.7692601 · Cited by 741
Self-citationFMR1 and the fragile X syndrome: Human genome epidemiology review
Crawford, D. C., Acuña, J. M., & Sherman, S. L. (2001) · Genetics in Medicine · doi:10.1097/00125817-200109000-00006 · Cited by 711
Protein Synthesis at Synaptic Sites on Dendrites
Steward, O., & Schuman, E. M. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.299 · Cited by 690
“In the first place, in situ hybridization analyses indicate that FMRP mRNA is not evident in dendrites of neurons in vivo (Hinds et al 1993, A nn u.”
BackgroundWeiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., Comery, T. A., Patel, B., Eberwine, J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5395 · Cited by 644
Dendritic Spine Structural Anomalies in Fragile-X Mental Retardation Syndrome
Irwin, S. A. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.10.1038 · Cited by 626
“Evidence for this comes from studies demonstrating high levels of FMRP expression in a number of tissues during embryonic development (Abitbol et al., 1993; Hinds et al., 1993), a period of massive cellular proliferation.”
BackgroundEvidence that fragile X mental retardation protein is a negative regulator of translation
Laggerbauer, B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.4.329 · Cited by 571
Feng, Y., Gutekunst, C.-A., Eberhart, D. E., Yi, H., Warren, S. T., & Hersch, S. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01539.1997 · Cited by 532
“…using in situ hybridization or immunocytochemistry have similarly detected abundant FMRP mRNA and protein and have suggested that it is especially abundant in hippocampal pyramidal cells, giant cholinergic neurons of the nucleus basalis, and the cerebellum (Devys et al., 1993; Hinds et al., 1993).”
InfluentialSelf-citationMolecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective
Santoro, M. R., Bray, S. M., & Warren, S. T. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132457 · Cited by 528
Self-citationFeng, Y., Absher, D., Eberhart, D. E., Brown, V., Malter, H. E., & Warren, S. T. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80012-x · Cited by 510
Self-citationA Decade of Molecular Studies of Fragile X Syndrome
O'Donnell, W. T., & Warren, S. T. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142909 · Cited by 481
“Furthermore, in situ hybridization andFmr1: β-galactosidase transcriptional fusion experiments have shown the expression pattern of murineFmr1 to be similar to the human version in both tissue specificity and time of expression (Hinds et al. 1993, Hergersberg 1995).”
BackgroundSelf-citationThe fragile X mental retardation protein inhibits translation via interacting with mRNA
Li, Z. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.11.2276 · Cited by 447
Siomi, H., Choi, M., Siomi, M. C., Nussbaum, R. L., & Dreyfuss, G. (1994) · Cell · doi:10.1016/0092-8674(94)90232-1 · Cited by 446
TRINUCLEOTIDE REPEAT EXPANSION AND HUMAN DISEASE
Ashley, C. T., & Warren, S. T. (1995) · Annual Review of Genetics · doi:10.1146/annurev.ge.29.120195.003415 · Cited by 395
Self-citationEberhart, D. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.8.1083 · Cited by 390
A Hierarchy of Hu RNA Binding Proteins in Developing and Adult Neurons
Okano, H. J., & Darnell, R. B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03024.1997 · Cited by 379
“However, although FMR-1 is expressed within most neurons, with some regional variation, it also is expressed outside of the nervous system (Abitbol et al., 1993; Devys et al., 1993; Hinds et al., 1993).”
BackgroundCompartmentalized Synthesis and Degradation of Proteins in Neurons
Steward, O., & Schuman, E. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00635-4 · Cited by 378
The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Bhakar, A. L., Dölen, G., & Bear, M. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153138 · Cited by 370
Understanding the molecular basis of fragile X syndrome
Jin, P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.901 · Cited by 369
“In situ hybridization with the adult mouse tissues showed abundant expression in brain, testes, ovary, esophageal epithelium, thymus, eye and spleen, with moderate expression in colon, uterus, thyroid and liver, and no expression in the heart, aorta or muscle (17).”
BackgroundAltered anxiety‐related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome
Spencer, C. M., Alekseyenko, O., Serysheva, E., Yuva‐Paylor, L. A., & Paylor, R. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00123.x · Cited by 349
“FMR1 mRNA is expressed at high levels during early development and in the brain and testis in adults (Devys et al. 1993; Hinds et al. 1993).”
BackgroundHuntington's disease gene (IT15) is widely expressed in human and rat tissues
Li, S.-H., Schilling, G., Young, W. S., Li, X., Margolis, R. L., Stine, O. C., Wagster, M. V., Abbott, M. H., Franz, M. L., Ranen, N. G., et al. (1993) · Neuron · doi:10.1016/0896-6273(93)90127-d · Cited by 347
“FMR-1 has relatively widespread expression, with high expression in the brain and testis, two of the tissues that are especially affected (Hinds et al., 1993).”
Characterization and localization of the FMR-1 gene product associated with fragile X syndrome
Verheij, C., Bakker, C. E., de Graaff, E., Keulemans, J., Willemsen, R., Verkerk, A. J. M. H., Galjaard, H., Reuser, A. J. J., Hoogeveen, A. T., & Oostra, B. A. (1993) · Nature · doi:10.1038/363722a0 · Cited by 343
Bhattacharya, A., Kaphzan, H., Alvarez-Dieppa, A. C., Murphy, J. P., Pierre, P., & Klann, E. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.022 · Cited by 316
“with postnatal expression limited to neurons and testes (Hinds et al., 1993).”
BackgroundParadee, W., Melikian, H. E., Rasmussen, D. L., Kenneson, A., Conn, P. J., & Warren, S. T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00285-7 · Cited by 305
Self-citationThe full mutation in the FMR–1 gene of male fragile X patients is absent in their sperm
Reyniers, E., Vits, L., De Boulle, K., Roy, B. V., Velzen, D. V., de Graaff, E., Verkerk, A. J. M. H., Jorens, H. Z. J., Darby, J. K., Oostra, B., et al. (1993) · Nature Genetics · doi:10.1038/ng0693-143 · Cited by 303
Restivo, L., Ferrari, F., Passino, E., Sgobio, C., Bock, J., Oostra, B. A., Bagni, C., & Ammassari-Teule, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504984102 · Cited by 299
Phenotypic variation and FMRP levels in fragile X
Loesch, D. Z., Huggins, R. M., & Hagerman, R. J. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20006 · Cited by 298
“A higher expression of FMRP has been documented in the human brain compared with other tissues [Hinds et al., 1993], especially in neuron-rich areas [Devys et al., 1993].”
BackgroundFragile X mice develop sensory hyperreactivity to auditory stimuli
Chen, L., & Toth, M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00036-7 · Cited by 345
Abitbol, M., Menini, C., Delezoide, A.-L., Rhyner, T., Vekemans, M., & Mallet, J. (1993) · Nature Genetics · doi:10.1038/ng0693-147 · Cited by 284
Wan, L., Dockendorff, T. C., Jongens, T. A., & Dreyfuss, G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8536-8547.2000 · Cited by 280
Siomi, M. C., Zhang, Y., Siomi, H., & Dreyfuss, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3825 · Cited by 271
“FMR1 is expressed at low levels in most adult tissues, but particularly high levels are found in the central nervous system and in the testes, which are two of the major organs affected in fragile X syndrome patients (1, 5, 12, 22 ).”
BackgroundLi, J., Pelletier, M. R., Perez Velazquez, J.-L., & Carlen, P. L. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1085 · Cited by 271
Ashley, C. T., Sutcliffe, J. S., Kunst, C. B., Leiner, H. A., Eichler, E. E., Nelson, D. L., & Warren, S. T. (1993) · Nature Genetics · doi:10.1038/ng0793-244 · Cited by 269
Self-citationDirect detection of novel expanded trinucleotide repeats in the human genome
Schalling, M., Hudson, T. J., Buetow, K. H., & Housman, D. E. (1993) · Nature Genetics · doi:10.1038/ng0693-135 · Cited by 268
Self-citationde Vries, B. B., Halley, D. J., Oostra, B. A., & Niermeijer, M. F. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.7.579 · Cited by 259
The fragile X mental retardation protein is associated with ribosomes
Khandjian, E. W., Corbin, F., Woerly, S., & Rousseau, F. (1996) · Nature Genetics · doi:10.1038/ng0196-91 · Cited by 251
Fragile X Mental Retardation Protein Regulates Translation by Binding Directly to the Ribosome
Chen, E., Sharma, M. R., Shi, X., Agrawal, R. K., & Joseph, S. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.023 · Cited by 249
“FMR1 encodes an RNA binding protein, Fragile Xmental retardation protein (FMRP) that is highly expressed in the brain (Ashley et al., 1993; Devys et al., 1993; Siomi et al., 1993, 1994; Hinds et al., 1993), and appears to regulate the expression of many proteins throughout the brain (Ashley et al.”
BackgroundLadd, P. D., Smith, L. E., Rabaia, N. A., Moore, J. M., Georges, S. A., Hansen, R. S., Hagerman, R. J., Tassone, F., Tapscott, S. J., & Filippova, G. N. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm293 · Cited by 248
“report ( 35 ). When we compare ASFMR1 expression with FMR1, we see that ASFMR1 is expressed in all of the tissues examined, with relatively high expression in brain and kidney (Fig. 5B, lanes 3 and 8) and barely detectable in heart, placenta, prostate, skeletal muscle, thyroid and trachea (Fig. 5B, lanes 7, 12‐14, 19…”
BackgroundFXR1, an autosomal homolog of the fragile X mental retardation gene.
Siomi, M. C., Siomi, H., Sauer, W. H., Srinivasan, S., Nussbaum, R. L., & Dreyfuss, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07237.x · Cited by 237
Rebar, R. W. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181a66843 · Cited by 234
Association of fragile X syndrome with delayed replication of the FMR1 gene
Hansen, R. S., Canfield, T. K., Lamb, M. M., Gartler, S. M., & Laird, C. D. (1993) · Cell · doi:10.1016/0092-8674(93)90365-w · Cited by 234
“FMR7 transcripts have been detected in diverse tissues (Hinds et al., 1993); the 5’ region of the gene contains a CpG island that is unmethylated on the active X chromosome and methylated on the inactive X chromosome (Hansen et al.”
BackgroundExamination of reproductive aging milestones among women who carry the FMR1premutation
Allen, E. G., Sullivan, A. K., Marcus, M., Small, C., Dominguez, C., Epstein, M. P., Charen, K., He, W., Taylor, K. C., & Sherman, S. L. (2007) · Human Reproduction · doi:10.1093/humrep/dem148 · Cited by 225
“FMR1 expression studies identified transcripts in granulosa cells of ovarian follicles (Hinds et al., 1993; Hergersberg et al., 1995).”
BackgroundHagerman, R. J., Hull, C. E., Safanda, J. F., Carpenter, I., Staley, L. W., O'Connor, R. A., Seydel, C., Mazzocco, M. M. M., Snow, K., Thibodeau, S. N., et al. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320510404 · Cited by 222
Self-citationBehavioral and neuroanatomical characterization of the Fmr1 knockout mouse
Mineur, Y. S., Sluyter, F., de Wit, S., Oostra, B. A., & Crusio, W. E. (2002) · Hippocampus · doi:10.1002/hipo.10005 · Cited by 216
“Although levels of FMRP do not remain constant during development (Abitbol et al., 1993), both mice and men show high levels at adult age, particularly in the hippocampus (Hinds et al., 1993).”
BackgroundSpencer, C. M., Alekseyenko, O., Hamilton, S. M., Thomas, A. M., Serysheva, E., Yuva‐Paylor, L. A., & Paylor, R. (2011) · Autism Research · doi:10.1002/aur.168 · Cited by 215
“The high degree of homology and the similarity of expression between the human and mouse genes [Abitbol et al., 1993; Hinds et al., 1993] make the mouse a good model system in which to study the role of genetic background on the variation among behavioral responses of individuals with FXS.”
BackgroundEvolutionary Conservation of Expression Profiles Between Human and Mouse Orthologous Genes
Liao, B.-Y., & Zhang, J. (2006) · Molecular Biology and Evolution · doi:10.1093/molbev/msj054 · Cited by 214
“Second, the expression pattern and function of human genes are often inferred from their mouse orthologs (e.g., Hinds et al. 1993), based on the assumption that these properties are conserved between the two species.”
BackgroundGrossman, A. W., Elisseou, N. M., McKinney, B. C., & Greenough, W. T. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.044 · Cited by 203
Sittler, A., Devys, D., Weber, C., & Mandel, J.-L. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.1.95 · Cited by 198
“It is very widely, but not ubiquitously expressed, as shown by in situ hybridization (9,10) or by Western blot or immunohistochemical analysis of the FMR1 protein (FMRP) ( 11–13).”
BackgroundFragile X premutation screening in women with premature ovarian failure
Conway, G. S., Payne, N. N., Webb, J., Murray, A., & Jacobs, P. A. (1998) · Human Reproduction · doi:10.1093/humrep/13.5.1184 · Cited by 199
Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis
Tamanini, F. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1315 · Cited by 198
“The developmental expression of the murine FXR1 gene was shown by RNA in situ hybridization (22), whereas the expression of FMRP has been characterized both at the RNA and protein level (6,23,24).”
BackgroundImmunocytochemical and Biochemical Characterization of FMRP, FXR1P, and FXR2P in the Mouse
Bakker, C. E., de Diego Otero, Y., Bontekoe, C., Raghoe, P., Luteijn, T., Hoogeveen, A. T., Oostra, B. A., & Willemsen, R. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4932 · Cited by 193
Genes with triplet repeats: candidate mediators of neuropsychiatric disorders
Ross, C. A., McInnis, M. G., Margolis, R. L., & Li, S.-H. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90175-l · Cited by 184
Evidence of Early Ovarian Aging in Fragile X Premutation Carriers
Welt, C. K., Smith, P. C., & Taylor, A. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0347 · Cited by 181
Fragile X Syndrome: The GABAergic System and Circuit Dysfunction
Paluszkiewicz, S. M., Martin, B. S., & Huntsman, M. M. (2011) · Developmental Neuroscience · doi:10.1159/000329420 · Cited by 178
“persists throughout development and into adulthood [Bakker et al., 2000; Hinds et al., 1993; Wang et al., 2004].”
iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth
Doers, M. E., Musser, M. T., Nichol, R., Berndt, E. R., Baker, M., Gomez, T. M., Zhang, S.-C., Abbeduto, L., & Bhattacharyya, A. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0030 · Cited by 165
“FMRP is expressed in many tissues, but is most abundant in neurons of the brain and in the testes [8–11].”
BackgroundA Novel RNA Transcript with Antiapoptotic Function Is Silenced in Fragile X Syndrome
Khalil, A. M., Faghihi, M. A., Modarresi, F., Brothers, S. P., & Wahlestedt, C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001486 · Cited by 172
“Northern blot analysis shows that FMR1 is expressed in the majority of the human tissues examined consistent with previous reports [20].”
BackgroundResultTransgenic mouse model for the fragile X syndrome
Kooy, R. F., D’Hooge, R., Reyniers, E., Bakker, C. E., Nagels, G., Boulle, K. D., Storm, K., Clincke, G., Deyn, P. P. D., Oostra, B. A., et al. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960809)64:2<241::aid-ajmg1>3.0.co;2-x · Cited by 206
Mosaicism in fragile X affected males
Nolin, S. L., Glicksman, A., Houck, G. E., Brown, W. T., & Dobkin, C. S. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320510444 · Cited by 164
The fragile X continuum: new advances and perspectives
Cornish, K., Turk, J., & Hagerman, R. (2008) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2008.01056.x · Cited by 161
Molecular Predictors of Cognitive Involvement in Female Carriers of Fragile X Syndrome
Taylor, A. K. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510310037035 · Cited by 150
FMRP Involvement in Formation of Synapses among Cultured Hippocampal Neurons
Braun, K. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.10.1045 · Cited by 149
“In human fetal brain as well as in mice the hippocampus is one of the major sites of Fmr1 gene expression (Abitbol et al., 1993; Hinds et al., 1993).”
BackgroundThe emerging fragile X premutation phenotype: Evidence from the domain of social cognition
Cornish, K., Kogan, C., Turk, J., Manly, T., James, N., Mills, A., & Dalton, A. (2005) · Brain and Cognition · doi:10.1016/j.bandc.2004.08.020 · Cited by 148
“…of FMRP in the brains of mouse embryos and to a lesser extent in human embryos reveal relatively higher levels of the protein in the cerebellum, suggesting that alterations in the function of FMRP might have a detrimental impact on this brain structure (Abitbol et al., 1993; Hinds et al., 1993).”
BackgroundInfluentialAschrafi, A., Cunningham, B. A., Edelman, G. M., & Vanderklish, P. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409803102 · Cited by 148
Association between idiopathic premature ovarian failure and fragile X premutation
Marozzi, A., Vegetti, W., Manfredini, E., Tibiletti, M. G., Testa, G., Crosignani, P. G., Ginelli, E., Meneveri, R., & Dalprà, L. (2000) · Human Reproduction · doi:10.1093/humrep/15.1.197 · Cited by 147
Barnea‐Goraly, N., Eliez, S., Hedeus, M., Menon, V., White, C. D., Moseley, M., & Reiss, A. L. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10035 · Cited by 140
Early developmental alterations in GABAergic protein expression in fragile X knockout mice
Adusei, D. C., Pacey, L. K. K., Chen, D., & Hampson, D. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.002 · Cited by 139
“species, thus making the mouse a suitable model for the study of this disorder (Hinds et al., 1993; Bakker et al., 2000).”
FMRP is associated to the ribosomes via RNA
Tamanini, F. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.6.809 · Cited by 137
“FMRP is widely expressed in various tissues with the highest expression in brain and testis ( 12 ,13) and its localization is cytoplasmic ( 3,5).”
BackgroundAutism: The Point of View from Fragile X Studies
Feinstein, C., & Reiss, A. L. (1998) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1026000404855 · Cited by 155
Molecular cytogenetic study of supernumerary marker chromosomes in an unselected group children
Gravholt, C. H., & Friedrich, U. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560124 · Cited by 134
Down syndrome consequent to a cryptic maternal 12p;21q chromosome translocation
Scott, J. A., Wenger, S. L., Steele, M. W., & Chakravarti, A. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560115 · Cited by 130
A nuclear role for the Fragile X mental retardation protein.
Fridell, R. A., Benson, R. E., Hua, J., Bogerd, H. P., & Cullen, B. R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00924.x · Cited by 139
“FMRP is expressed in many human tissues, including particularly the brain, and is found predominantly in the cell cytoplasm, although occasional nuclear staining has been reported (Devys et al., 1993; Hinds et al., 1993; Verheij et al., 1993).”
BackgroundRNA-binding proteins in neurological development and disease
Prashad, S., & Gopal, P. P. (2020) · RNA Biology · doi:10.1080/15476286.2020.1809186 · Cited by 128
“FMRP is predominantly expressed in granule layers of the hippocampus and cerebellum during early stages of neurodevelopment [18].”
BackgroundFragile X syndrome: from molecular genetics to therapy
D’Hulst, C., & Kooy, R. F. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.064667 · Cited by 125
“FMRP is highly conserved among vertebrates and is widely, but not ubiquitously, expressed. Particularly high expression is observed in ovary, thymus, eye, spleen and oesophageal epithelium with an abundant expression in brain and testis. A moderate expression of FMRP has been demonstrated in colon, uterus, thyroid and…”
BackgroundOf Men and Mice: Modeling the Fragile X Syndrome
Dahlhaus, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00041 · Cited by 139
“Since FMRP itself is developmentally regulated (Hinds et al., 1993) and was found to function in neuronal migration, differentiation and dendritic spine maturation (Hinton et al., 1991; Irwin et al., 2001; Saffary and Xie, 2011; Telias et al., 2013; La Fata et al., 2014; Khalfallah et al., 2017),…”
BackgroundSpencer, C. M., Serysheva, E., Yuva-Paylor, L. A., Oostra, B. A., Nelson, D. L., & Paylor, R. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl121 · Cited by 118
“FMRP is highly expressed in adult brain and testis, organs that are most affected in FXS (27).”
BackgroundSelf-citationTrinucleotide repeat expansions and human genetic disease
Bates, G. P., & Lehrach, H. (1994) · BioEssays · doi:10.1002/bies.950160411 · Cited by 125
Zhang, Z., Marro, S. G., Zhang, Y., Arendt, K. L., Patzke, C., Zhou, B., Fair, T., Yang, N., Südhof, T. C., Wernig, M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar4338 · Cited by 113
The FMR1 gene and fragile X‐associated tremor/ataxia syndrome
Brouwer, J. R., Willemsen, R., & Oostra, B. A. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30910 · Cited by 113
“detected in glia and oligodendrocytes [Abitbol et al., 1993; Devys et al., 1993; Hinds et al., 1993; Wang et al., 2004; Pacey and Doering, 2007].”
BackgroundTamanini, F., Bontekoe, C., Bakker, C. E., van Unen, L., Anar, B., Willemsen, R., Yoshida, M., Galjaard, H., Oostra, B. A., & Hoogeveen, A. T. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.863 · Cited by 112
Fragile X-associated disorders: a clinical overview
Gallagher, A. T., & Hallahan, B. P. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6161-3 · Cited by 131
“FMRP is abundant in neurons, particularly those in the cerebral cortex, cerebellum and hippocampus [94, 95 ], and is also present in other tissues, including spermatogonia and various epithelial tissues.”
BackgroundSensitive time-windows for susceptibility in neurodevelopmental disorders
Meredith, R. M., Dawitz, J., & Kramvis, I. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.03.005 · Cited by 115
Eadie, B. D., Cushman, J., Kannangara, T. S., Fanselow, M. S., & Christie, B. R. (2012) · Hippocampus · doi:10.1002/hipo.20890 · Cited by 103
“This protein is expressed throughout the body, but is highly expressed in dentate gyrus (DG) granule neurons (Hinds et al., 1993).”
BackgroundBaker, K. B., Wray, S. P., Ritter, R., Mason, S., Lanthorn, T. H., & Savelieva, K. V. (2010) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00585.x · Cited by 106
“In addition, Fragile X Mental Retardation 1 (FMR1) expression is high in the hippocampus (Hinds et al. 1993).”
BackgroundThe Fragile X Family of Disorders: A Model for Autism and Targeted Treatments
Hagerman, R., Rivera, S., & Hagerman, P. (2008) · Current Pediatric Reviews · doi:10.2174/157339608783565770 · Cited by 100
Pop, A. S., Gomez‐Mancilla, B., Neri, G., Willemsen, R., & Gasparini, F. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3330-3 · Cited by 110
“High levels are found in the hippocampus and cerebellum, and there is moderate expression in the cerebral cortex (Abitbol et al. 1993; Devys et al. 1993; Hinds et al. 1993; Khandjian et al. 1995).”
BackgroundInteraction of the Transcription Factors USF1, USF2, and α-Pal/Nrf-1 with the FMR1 Promoter
Kumari, D., & Usdin, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009629200 · Cited by 92
Fragile-X: neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes.
Jäkälä, P., Hänninen, T., Ryynänen, M., Laakso, M., Partanen, K., Mannermaa, A., & Soininen, H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119538 · Cited by 93
ALDB: A Domestic-Animal Long Noncoding RNA Database
Li, A., Zhang, J., Zhou, Z., Wang, L., Liu, Y., & Liu, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124003 · Cited by 94
“Tissue-specific expression of genes tend to provide evidence for their function roles[44].”
BackgroundAdinolfi, S., Ramos, A., Martin, S. R., Dal Piaz, F., Pucci, P., Bardoni, B., Mandel, J. L., & Pastore, A. (2003) · Biochemistry · doi:10.1021/bi034909g · Cited by 92
Altered maturation of the primary somatosensory cortex in a mouse model of fragile X syndrome
Till, S. M., Wijetunge, L. S., Seidel, V. G., Harlow, E., Wright, A. K., Bagni, C., Contractor, A., Gillingwater, T. H., & Kind, P. C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds030 · Cited by 91
“This is consistent with studies that demonstrate that Fmr1 mRNA is highly expressed in the brain during development (15), and suggests that FMRP may play a role in establishing and refining the morphologic features of the somatosensory cortex.”
ResultThe Fragile X mental retardation protein
Bardoni, B., Schenck, A., & Mandel, J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00647-5 · Cited by 107
Kumari, D., & Usdin, K. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq394 · Cited by 103
Cardiovascular indices of physiological arousal in boys with fragile X syndrome
Roberts, J. E., Boccia, M. L., Bailey, D. B., Hatton, D. D., & Skinner, M. (2001) · Developmental Psychobiology · doi:10.1002/dev.1035 · Cited by 88
A theoretical analysis of the role of hyperarousal in the learning and behavior of fragile X males
Cohen, I. L. (1995) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1410010410 · Cited by 88
Moon, J., Beaudin, A. E., Verosky, S., Driscoll, L. L., Weiskopf, M., Levitsky, D. A., Crnic, L. S., & Strupp, B. J. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.6.1367 · Cited by 88
Cornish, K. M., Turk, J., Wilding, J., Sudhalter, V., Munir, F., Kooy, F., & Hagerman, R. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.t01-1-00297.x · Cited by 86
Metadata
- Authors
- Hinds, H. L., Ashley, C. T., Sutcliffe, J. S., Nelson, D. L., Warren, S. T., Housman, D. E., & Schalling, M.
- Affiliations
- Massachusetts Institute of Technology (US)
- Howard Hughes Medical Institute (US)
- Venue
- Nature Genetics
- Published
- 1993-01-01
- Volume
- 3
- Issue
- 1
- Pages
- 36-43
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2014102314
- Cited by
- 396
- References
- 40
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 10 · 2022: 4 · 2021: 15 · 2020: 10 · 2019: 11 · 2018: 11 · 2017: 8 · 2016: 10 · 2015: 11 · 2014: 20 · 2013: 13 · 2012: 15
- FWCI
- 17.04
- Type
- journal article
- Language
- en
- Update notices
- correction (1993-11-01)
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hd029256-10)
- National Heart, Lung, and Blood Institute (5-P01-HL41484, P01HL041484)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 20521, 1 R01-HD29256)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Developmental Neuroscience › Williams Syndrome Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Keywords
- FMR1 gene, fragile X syndrome, tissue-specific gene expression, embryonic development, brain expression, testicular tubules, mRNA in situ hybridization, Fmr1 knockout mice
- MeSH terms
- Adult, Animals, Base Sequence, Brain, DNA, Single-Stranded, Fetus, Fragile X Syndrome, Humans, Male, Molecular Sequence Data, Nerve Tissue Proteins, Organ Specificity, Testis, Blotting, Northern, Gene Expression, RNA-Binding Proteins, In Situ Hybridization, Mice, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.